1. Home
  2. EVH vs HPS Comparison

EVH vs HPS Comparison

Compare EVH & HPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolent Health Inc

EVH

Evolent Health Inc

HOLD

Current Price

$5.42

Market Cap

469.0M

ML Signal

HOLD

Logo John Hancock Preferred Income Fund III Preferred Income Fund III

HPS

John Hancock Preferred Income Fund III Preferred Income Fund III

HOLD

Current Price

$14.58

Market Cap

465.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVH
HPS
Founded
2011
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Investment Managers
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
469.0M
465.8M
IPO Year
2015
2003

Fundamental Metrics

Financial Performance
Metric
EVH
HPS
Price
$5.42
$14.58
Analyst Decision
Strong Buy
Analyst Count
15
0
Target Price
$7.93
N/A
AVG Volume (30 Days)
2.5M
52.7K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$907,957,000.00
N/A
Revenue This Year
$33.89
N/A
Revenue Next Year
$15.84
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$13.80
52 Week High
$11.81
$15.68

Technical Indicators

Market Signals
Indicator
EVH
HPS
Relative Strength Index (RSI) 61.29 55.45
Support Level $3.67 $14.42
Resistance Level $8.30 $14.70
Average True Range (ATR) 0.36 0.14
MACD 0.04 0.03
Stochastic Oscillator 66.54 80.00

Price Performance

Historical Comparison
EVH
HPS

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.

About HPS John Hancock Preferred Income Fund III Preferred Income Fund III

John Hancock Preferred Income Fund III is a closed-end, diversified management investment company. Its investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve the objectives by investing a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. The portfolio composition of the company consists of the U.S. preferred securities, foreign preferred securities, common stocks, corporate bonds, and the short-term investments.

Share on Social Networks: